These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

252 related items for PubMed ID: 20102506

  • 21. Effect of prespecified therapy escalation on plasma NT-proBNP concentrations in dogs with stable congestive heart failure due to myxomatous mitral valve disease.
    Hezzell MJ, Block CL, Laughlin DS, Oyama MA.
    J Vet Intern Med; 2018 Sep; 32(5):1509-1516. PubMed ID: 30216549
    [Abstract] [Full Text] [Related]

  • 22. Treatment of dogs with compensated myxomatous mitral valve disease with spironolactone-a pilot study.
    Hezzell MJ, Boswood A, López-Alvarez J, Lötter N, Elliott J.
    J Vet Cardiol; 2017 Aug; 19(4):325-338. PubMed ID: 28734620
    [Abstract] [Full Text] [Related]

  • 23. Factors affecting the urinary aldosterone-to-creatinine ratio in healthy dogs and dogs with naturally occurring myxomatous mitral valve disease.
    Galizzi A, Bagardi M, Stranieri A, Zanaboni AM, Malchiodi D, Borromeo V, Brambilla PG, Locatelli C.
    BMC Vet Res; 2021 Jan 07; 17(1):15. PubMed ID: 33413406
    [Abstract] [Full Text] [Related]

  • 24. Effect of benazepril on survival and cardiac events in dogs with asymptomatic mitral valve disease: a retrospective study of 141 cases.
    Pouchelon JL, Jamet N, Gouni V, Tissier R, Serres F, Carlos Sampedrano C, Castaignet M, Lefebvre HP, Chetboul V.
    J Vet Intern Med; 2008 Jan 07; 22(4):905-14. PubMed ID: 18482278
    [Abstract] [Full Text] [Related]

  • 25. Efficacy of enalapril for prevention of congestive heart failure in dogs with myxomatous valve disease and asymptomatic mitral regurgitation.
    Kvart C, Häggström J, Pedersen HD, Hansson K, Eriksson A, Järvinen AK, Tidholm A, Bsenko K, Ahlgren E, Ilves M, Ablad B, Falk T, Bjerkfås E, Gundler S, Lord P, Wegeland G, Adolfsson E, Corfitzen J.
    J Vet Intern Med; 2002 Jan 07; 16(1):80-8. PubMed ID: 11822810
    [Abstract] [Full Text] [Related]

  • 26. [Idiopathic hypereosinophilia with cardiac involvement].
    Martin N, Ott R, Klues HG.
    Dtsch Med Wochenschr; 2004 Mar 12; 129(11):557-60. PubMed ID: 14997406
    [Abstract] [Full Text] [Related]

  • 27. Impact of a combination of pimobendan, furosemide, and enalapril on heart rate variability in naturally occurring, symptomatic, myxomatous mitral valve degeneration dogs.
    Pirintr P, Saengklub N, Boonpala P, Hamlin RL, Kijtawornrat A.
    BMC Vet Res; 2023 Oct 12; 19(1):201. PubMed ID: 37821927
    [Abstract] [Full Text] [Related]

  • 28. The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators.
    Pitt B, Zannad F, Remme WJ, Cody R, Castaigne A, Perez A, Palensky J, Wittes J.
    N Engl J Med; 1999 Sep 02; 341(10):709-17. PubMed ID: 10471456
    [Abstract] [Full Text] [Related]

  • 29. Efficacy of oral torasemide in dogs with degenerative mitral valve disease and new onset congestive heart failure: The CARPODIEM study.
    Besche B, Blondel T, Guillot E, Garelli-Paar C, Oyama MA.
    J Vet Intern Med; 2020 Sep 02; 34(5):1746-1758. PubMed ID: 32767627
    [Abstract] [Full Text] [Related]

  • 30. Pharmacologic management of myxomatous mitral valve disease in dogs.
    Atkins CE, Häggström J.
    J Vet Cardiol; 2012 Mar 02; 14(1):165-84. PubMed ID: 22386553
    [Abstract] [Full Text] [Related]

  • 31. The SEISICAT study: a pilot study assessing efficacy and safety of spironolactone in cats with congestive heart failure secondary to cardiomyopathy.
    James R, Guillot E, Garelli-Paar C, Huxley J, Grassi V, Cobb M.
    J Vet Cardiol; 2018 Feb 02; 20(1):1-12. PubMed ID: 29277469
    [Abstract] [Full Text] [Related]

  • 32. Echocardiographic predictors of survival in dogs with myxomatous mitral valve disease.
    Sargent J, Muzzi R, Mukherjee R, Somarathne S, Schranz K, Stephenson H, Connolly D, Brodbelt D, Fuentes VL.
    J Vet Cardiol; 2015 Mar 02; 17(1):1-12. PubMed ID: 25586168
    [Abstract] [Full Text] [Related]

  • 33. Mitral Regurgitation Severity and Left Ventricular Systolic Dimension Predict Survival in Young Cavalier King Charles Spaniels.
    Reimann MJ, Møller JE, Häggström J, Martinussen T, Zatrazemi SSC, Svanholm L, Nielsen LBM, Pedersen HD, Olsen LH.
    J Vet Intern Med; 2017 Jul 02; 31(4):1008-1016. PubMed ID: 28573754
    [Abstract] [Full Text] [Related]

  • 34. Chordae tendineae rupture in dogs with degenerative mitral valve disease: prevalence, survival, and prognostic factors (114 cases, 2001-2006).
    Serres F, Chetboul V, Tissier R, Sampedrano CC, Gouni V, Nicolle AP, Pouchelon JL.
    J Vet Intern Med; 2007 Jul 02; 21(2):258-64. PubMed ID: 17427386
    [Abstract] [Full Text] [Related]

  • 35. Effect of pimobendan on case fatality rate in Doberman Pinschers with congestive heart failure caused by dilated cardiomyopathy.
    O'Grady MR, Minors SL, O'Sullivan ML, Horne R.
    J Vet Intern Med; 2008 Jul 02; 22(4):897-904. PubMed ID: 18537880
    [Abstract] [Full Text] [Related]

  • 36. The effect of furosemide on left atrial pressure in dogs with mitral valve regurgitation.
    Suzuki S, Ishikawa T, Hamabe L, Aytemiz D, Huai-Che H, Fukushima R, Machida N, Tanaka R.
    J Vet Intern Med; 2011 Jul 02; 25(2):244-50. PubMed ID: 21314718
    [Abstract] [Full Text] [Related]

  • 37. Clinical findings and survival time in dogs with advanced heart failure.
    Beaumier A, Rush JE, Yang VK, Freeman LM.
    J Vet Intern Med; 2018 May 02; 32(3):944-950. PubMed ID: 29635788
    [Abstract] [Full Text] [Related]

  • 38. Geriatric heart diseases in dogs.
    Hamlin RL.
    Vet Clin North Am Small Anim Pract; 2005 May 02; 35(3):597-615. PubMed ID: 15833561
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Efficacy and safet of pimobendan in canine heart failure caused by myxomatous mitral valve disease.
    Smith PJ, French AT, Van Israël N, Smith SG, Swift ST, Lee AJ, Corcoran BM, Dukes-McEwan J.
    J Small Anim Pract; 2005 Mar 02; 46(3):121-30. PubMed ID: 15789807
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 13.